European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making
Nicolaus Andratschke(University Hospital of Zurich), Carsten Nieder(UiT The Arctic University of Norway), Yvette M. van der Linden(Netherlands Comprehensive Cancer Organisation), Peter Hoskin(University of Manchester), Philip Poortmans(Université Paris Sciences et Lettres), N. Reynaert(Institut Jules Bordet), Najlaa Alyamani(European Organisation for Research and Treatment of Cancer), Panagiotis Balermpas(Goethe University Frankfurt), Maximilian Niyazi(German Cancer Research Center), Jonas Willmann(University of North Texas), Coen Hurkmans(Radboud University Nijmegen), Brigitta G. Baumert(University of Bonn), Ane Appelt(University of Leeds), Orit Kaidar‐Person(Dana-Farber Cancer Institute), Morten Høyer(Aarhus University Hospital), Icro Meattini(Azienda Ospedaliero-Universitaria Careggi), Johannes A. Langendijk(University of Groningen), Dirk De Ruysscher(Maastricht University Medical Centre), Stephanie Tanadini‐Lang(University of Zurich)
Cited by 192
Related Papers
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k